Different respiratory infections such as covid-19, influenza, RSV and the common cold are widespread in our country this winter and this is reflected in the purchase of cough and cold products. In December, the turnover of these products reached 120.5 million euros, an increase of 57.9% compared with the same period last year.Therefore, it can be expressed as medical observation station, Collect data from consulting firms IQVIA.
Specifically, the turnover in 2023 will be 755.6 million, an increase of 9.68% over the 2022 data.
As for masks, it also increased by 139.7% compared with the previous month, with a total turnover of 5.3 million euros. However, the evolution of mask turnover fell by 84%, with a higher turnover last year of 64 million euros compared with 365.5 million euros in 2022.
The same happened with covid-19 testing, where sales increased by 146% in December, reaching a turnover of 5.5 million euros.
On an annual basis, it has been recorded in Annual Mobility Trends (MAT) 12/23 Turnover was €41.2 million, while Mat 12/22 The registered amount is 383.5 million euros. A decrease of 89.2% compared with the previous year. Of course, overall, the total market volume will increase by 4% in 2023.
Behavior of the Pharmaceutical and Consumer Health Markets in 2023
The total pharmacy market is €23.669 billion, including pharmaceuticals and all consumer health categories.
Drugs accounted for 70.1% of total pharmacy sales. Among them, prescription drugs were US$16.586 billion and over-the-counter drugs were US$1.575 billion, part of which were financing drugs.
Within consumer health (CH) products, the largest component is over-the-counter (OTC) pharmaceuticals, accounting for 13.1% of the market share. (Including 1.575 billion financing of over-the-counter drugs)
The next most important category is personal care products (PEC), accounting for 7.6%. This is followed by patient care products (PAC), which accounts for 6.3% of the market share, and nutritional products (NUT), which accounts for only 3% of pharmaceutical sales.
We will continue to inform…